When the FDA awarded Biohaven Pharmaceuticals’ migraine med Nurtec ODT with a second indication last month, the company paraded the drug as the only option to both prevent and treat migraines. Now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results